Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,225 studies match

clinicaltrialsPublishedShowing 1–50 of 1,225 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03837899	Durvalumab and Tremelimumab for Pediatric Malignancies	active not recruiting	Phase 1 / Phase 2	50	AstraZenecaINDUSTRY	7	Sep 29, 2026	clinicaltrials
NCT05927142	Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy(DURIPANC)	active not recruiting	Phase 1 / Phase 2	43	Joachim Aerts, MD PhDOTHER	1	Sep 29, 2026